Mantram Repetition Versus Health Education for Veterans With PTSD and Chronic Pain
Randomized Controlled Trial of Mantram Repetition Program Versus Health and Wellness Psychoeducation for Veterans With Comorbid Posttraumatic Stress Disorder and Chronic Pain
2 other identifiers
interventional
170
1 country
1
Brief Summary
Approximately 450,000 Veterans Health Administration service users have both posttraumatic stress disorder (PTSD) and chronic pain (CP); treatments that efficiently target both PTSD and CP are limited, and new interventions should address the unique needs of Veterans with PTSD/CP. Mantram Repetition Program (MRP), a meditation-based program, appears well-suited to address these high-priority VA needs. MRP has established effectiveness for treatment of PTSD, is broadly acceptable, can be learned quickly and applied flexibly. However, rigorous testing is needed for pain-related outcomes among a PTSD/CP population. The proposed study will include a randomized controlled trial comparing the efficacy of MRP for PTSD/CP to Health Education while Living with Pain among a sample of 170 Veterans with comorbid PTSD/CP. The primary outcomes will be PTSD symptoms and pain interference. Results from this study will directly inform patient care among the nearly 4% of Veterans with PTSD/CP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2027
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedStudy Start
First participant enrolled
April 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2030
Study Completion
Last participant's last visit for all outcomes
September 30, 2030
July 27, 2026
July 1, 2026
3 years
July 21, 2026
July 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Revised Clinician-Administered PTSD scale for DSM-5 (CAPS-5-R)
The CAPS-5-R is a widely-used, well-validated clinician interview that diagnoses PTSD and assesses the severity of PTSD symptoms. Total severity scores range from 0-200, with higher scores indicated greater severity.
0, 5, 10, 20 weeks
Patient Reported Outcome Short Form Pain Interference (PROMIS-PI short form v1.1)
The PROMIS-PI short form is a self-report measure of pain-related functional interference. PROMIS-PI items are self-rated from 1 to 5; responses range from 1 ("not at all") to 5 ("very much"). The PROMIS-PI is psychometrically sound and provides meaningful estimates of change in pain interference in clinical samples.
0, 5, 10, 20 weeks
Secondary Outcomes (2)
Insomnia Severity Index (ISI)
0, 5, 10, 20 weeks
Pre-Sleep Arousal Scale (PSAS)
0, 5, 10, 20 weeks
Study Arms (2)
mantram repetition program
EXPERIMENTAL8-session group-based meditation training class led by a trained instructor
health education
ACTIVE COMPARATOR8-session group-based health education and discussion led by a trained instructor
Interventions
manualized Mantram Repetition Program adapted for Veterans with PTSD and chronic pain
manualized health and wellness psychoeducation and discussion group
Eligibility Criteria
You may qualify if:
- U.S. Veteran
- Diagnosis of PTSD
- Chronic, non-malignant pain:
- (a) pain most days (\> 3 days/week) for at least 6 months
- (b) average pain severity and interference with enjoyment of life and/or general
- Willing/able to engage in study activities
You may not qualify if:
- Significant current risk of suicide or homicide
- Untreated severe alcohol or substance use disorder
- Untreated/unstable serious mental health disorders, such as psychotic disorders, bipolar disorder, or serious dissociative symptoms
- Impaired mental status
- Concurrent interventions specifically targeting PTSD or CP or social functioning (e.g., couples therapy) or any meditative or mind-body intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161-0002, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne L Malaktaris
VA San Diego Healthcare System, San Diego, CA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome evaluator is blind to experimental condition
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2026
First Posted
July 24, 2026
Study Start (Estimated)
April 1, 2027
Primary Completion (Estimated)
April 1, 2030
Study Completion (Estimated)
September 30, 2030
Last Updated
July 27, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Specific parameters of sharing are not yet established